dalteparin has been researched along with Proliferative Vitreoretinopathy in 2 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| " Intraoperative bleeding, postoperative fibrin, hyphema and vitreous hemorrhage were graded in an unmasked fashion using previously described grading scales." | 3.73 | A prospective, open-label, dose-escalating study of low molecular weight heparin during repeat vitrectomy for PVR and severe diabetic retinopathy. ( Jumper, JM; Lane, RG; MacCumber, MW; McCuen, BW; Nasir, MA, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lane, RG | 1 |
| Jumper, JM | 1 |
| Nasir, MA | 1 |
| MacCumber, MW | 1 |
| McCuen, BW | 1 |
| Schaub, F | 1 |
| Schiller, P | 1 |
| Hoerster, R | 1 |
| Kraus, D | 1 |
| Holz, FG | 1 |
| Guthoff, R | 1 |
| Agostini, H | 1 |
| Spitzer, MS | 1 |
| Wiedemann, P | 1 |
| Lommatzsch, A | 1 |
| Boden, KT | 1 |
| Dimopoulos, S | 1 |
| Bemme, S | 1 |
| Tamm, S | 1 |
| Maier, M | 1 |
| Roider, J | 1 |
| Enders, P | 1 |
| Altay, L | 1 |
| Fauser, S | 1 |
| Kirchhof, B | 1 |
1 trial available for dalteparin and Proliferative Vitreoretinopathy
| Article | Year |
|---|---|
Intravitreal 5-Fluorouracil and Heparin to Prevent Proliferative Vitreoretinopathy: Results from a Randomized Clinical Trial.
Topics: Dalteparin; Double-Blind Method; Fluorouracil; Heparin; Heparin, Low-Molecular-Weight; Humans; Retin | 2022 |
1 other study available for dalteparin and Proliferative Vitreoretinopathy
| Article | Year |
|---|---|
A prospective, open-label, dose-escalating study of low molecular weight heparin during repeat vitrectomy for PVR and severe diabetic retinopathy.
Topics: Diabetic Retinopathy; Enoxaparin; Female; Fibrin; Fibrinolytic Agents; Humans; Hyphema; Infusion Pum | 2005 |